BioCardia, Inc. Prepaid Expense, Current
BioCardia, Inc. (BCDA) had Prepaid Expense, Current of $445.00 thousand as of 2018-12-31, per its 10-K filed 2019-04-02.
Discontinued › Balance Sheet › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2019-04-02
- 2018-12-31: Prepaid Expense, Current $445.00K.
- 2018-09-30: Prepaid Expense, Current $224.00K.
- 2018-06-30: Prepaid Expense, Current $282.00K.
- 2018-03-31: Prepaid Expense, Current $277.00K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2018-12-31 | $445.00K 10-K · filed 2019-04-02 |
| 2018-09-30 | $224.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $282.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $277.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $340.00K 10-K · filed 2019-04-02 |
| 2017-09-30 | $188.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $282.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $252.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $356.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $146.00K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |